Potential issues may include: Underdosed products Poor peptide quality Inconsistent administration Protocols that are too short Concentrations that are too low for the severity of the condition In many situations, the issue may not be that peptides do not work, but rather that the body is not receiving adequate and consistent support for long enough
Hypericum Depression Trial Study Group, Davidson JR, Gadde KM, Fairbank JA, Krishnan KRR, Califf RM, Binanay C, Parker CB, Pugh N, Hartwell TD, Vitiello B, Ritz L, Severe J, Cole JO, de Battista C, Doraiswamy PM, Feighner JP, Keck P, Kelsey J, Lin KM, Londborg PD, Nemeroff CB, Schatzberg AF, Sheehan DV, Srivastava RK, Taylor L, Trivedi MH, Weisler RH
Appl Microbiol Biotechnol 77:12331240
All these processes are modulated by the inflammatory microenvironment formed in previous stages (105)